Optiflux® High Flux Dialyzers

Clinically Proven Albumin-sparing Design4


Keep Albumin Where It Belongs

Dialyzers help rid waste from your patient's bloodstream. But what if they're also losing something beneficial?

Optiflux® high flux dialyzers are designed to help patients limit albumin loss. In fact, in a retrospective data analysis, patients using the Optiflux dialyzer were observed to have significant increases (0.07 g/dL) in mean serum albumin after six months of treatments.1

For details, watch our short product video or download our Why Albumin Matters brochure.


Video player requires JavaScript enabled. You can watch this video here: https://www.youtube.com/watch?v=G_c9FHU1494&showinfo=0


Clinical Perspectives on Acceptable Albumin Loss per Treatment2

A recent perception survey shows that most nephrologists won't tolerate albumin loss during dialysis.


financial management

1g of Albumin Loss

72% of nephrologists find 1g of albumin loss level per treatment acceptable

financial management

2g of Albumin Loss

41% of nephrologists find 2g of albumin loss level per treatment acceptable

financial management

3g of Albumin Loss

27% of nephrologists find 3g of albumin loss level per treatment acceptable


Physician Opinions2

In the recent perception survey, we asked physicians why they would probably or definitely switch from current high-flux dialyzers if albumin loss was 2g, 3g, or 4g. Here's what they said: 


"Patient care impact and potential cost if replacement albumin is required."

"It is very hard for many patients to increase their protein intake to make up for this."

"Too much loss. Malnutrition is too big a problem."

"Hypoalbuminemia is one of the biggest patient risk factors and one of the hardest things to treat!"

Your Patients Rely on You. You Can Rely on Optiflux.

Reliable efficacy has made Optiflux dialyzers the time-tested choice of clinicians around the country, which is why we've achieved a landmark of 550 million+ treatments. And with the largest dialyzer manufacturing facility in the US, and a fleet of TruBlu delivery vehicles, customers can count on us to provide what they need, when they need it.

For more evidence of how we help you and your patients, see our proof points below.



financial management

Treatment Adequacy

Mean spKt/V of 1.9 ± 0.313,4 in a controlled study of 17 subjects.


financial management

Albumin-sparing Design

Albumin loss below the detection limit of 0.3 g per treatment4 means patients retain nearly all of this vital protein.


financial management

No Evidence of Overt Complement Activation3

financial management

Quality You Can Quantify

Low customer complaint rates6 reflect reliable performance and engineering.


financial management

Supply You Can Count On

Manufactured locally in the US in a facility producing over 55 million dialyzers a year.6


financial management

Delivery You Can Depend On

Distribution centers in key locations, a fleet of long-haul trucks, and a 99% order fill rate.7